Sanofi-Aventis U.S. LLC v. IMPAX Laboratories, Inc.

COMPLAINT FOR PATENT INFRINGEMENT filed against IMPAX Laboratories, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2057674.) - filed by Genzyme Corporation, Sanofi-Aventis U.S. LLC, Aventisub LLC, Sanofi. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(jcs) (Entered: 01/03/2017)

2017-01-03

1

Download

COMPLAINT FOR PATENT INFRINGEMENT filed against IMPAX Laboratories, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2057674.) - filed by Genzyme Corporation, Sanofi-Aventis U.S. LLC, Aventisub LLC, Sanofi. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(jcs) (Entered: 01/03/2017)

2017-01-03

2

View

COMPLAINT FOR PATENT INFRINGEMENT filed against IMPAX Laboratories, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2057674.) - filed by Genzyme Corporation, Sanofi-Aventis U.S. LLC, Aventisub LLC, Sanofi. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(jcs) (Entered: 01/03/2017)

2017-01-03

2

View

COMPLAINT FOR PATENT INFRINGEMENT filed against IMPAX Laboratories, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2057674.) - filed by Genzyme Corporation, Sanofi-Aventis U.S. LLC, Aventisub LLC, Sanofi. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(jcs) (Entered: 01/03/2017)

2017-01-03

2

View

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jcs) (Entered: 01/03/2017)

2017-01-03

1

View

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: November 21, 2016. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 5/21/2019. (jcs) (Entered: 01/03/2017)

2017-01-03

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 6,794,410 C1; US 9,186,346 B2. (jcs) (Entered: 01/03/2017)

2017-01-03

1

View

No Summons Issued

2017-01-03

1

No Actions

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sanofi for Aventisub LLC, Genzyme Corporation, Sanofi-Aventis U.S. LLC filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. (Bove, Jeffrey) (Entered: 01/04/2017)

2017-01-04

1

View

Summons Issued

2017-01-04

1

No Actions

Summons Issued with Magistrate Consent Notice attached as to IMPAX Laboratories, Inc. on 1/4/2017. (jcs)

2017-01-04

1

No Actions

SUMMONS Returned Executed by Genzyme Corporation, Sanofi-Aventis U.S. LLC, Aventisub LLC, Sanofi. IMPAX Laboratories, Inc. served on 1/4/2017, answer due 1/25/2017. (Bove, Jeffrey) (Entered: 01/05/2017)

2017-01-05

1

View

Case Assigned/Reassigned

2017-01-11

1

No Actions

Case Assigned to Judge Gregory M. Sleet. Please include the initials of the Judge (GMS) after the case number on all documents filed. Associated Cases: 1:17-cv-00003-GMS, 1:17-cv-00004-GMS, 1:17-cv-00018-GMS, 1:17-cv-00019-GMS (rjb)

2017-01-11

1

No Actions

STIPULATION TO EXTEND TIME to Answer, Move or Otherwise Respond to Complaint to January 25, 2017 - filed by IMPAX Laboratories, Inc.. (Phillips, John) (Entered: 01/12/2017)

2017-01-12

1

View

~Util - Set/Reset Answer Deadline AND SO ORDERED

2017-01-17

1

No Actions

SO ORDERED - re 7 STIPULATION TO EXTEND TIME to Answer, Move or Otherwise Respond to Complaint to January 25, 2017 filed by IMPAX Laboratories, Inc., Set/Reset Answer Deadlines: IMPAX Laboratories, Inc. answer due 2/24/2017. Ordered by Judge Gregory M. Sleet on 1/17/2017. (mdb)

2017-01-17

1

No Actions

NOTICE of Appearance by David A. Bilson on behalf of IMPAX Laboratories, Inc. (Bilson, David) (Entered: 01/18/2017)

2017-01-18

1

View

Amended Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 11/21/2016. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 3/12/2020. (Bove, Jeffrey) (Entered: 01/20/2017)

2017-01-20

1

View

STIPULATION TO EXTEND TIME To Answer, Move or Otherwise Respond to the Complaint to March 27, 2017 - filed by IMPAX Laboratories, Inc.. (Phillips, John) (Entered: 02/17/2017)

2017-02-17

1

View

MOTION for Pro Hac Vice Appearance of Attorney Paul H. Berghoff, Alison J. Baldwin, Paula S. Fritsch, Ann C. Palma, and Brandon J. Kennedy - filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. (Bove, Jeffrey) (Entered: 02/22/2017)

2017-02-22

1

View

~Util - Set/Reset Answer Deadline AND SO ORDERED

2017-02-22

1

No Actions

SO ORDERED - re 10 STIPULATION TO EXTEND TIME To Answer, Move or Otherwise Respond to the Complaint to March 27, 2017 filed by IMPAX Laboratories, Inc., Set/Reset Answer Deadlines: IMPAX Laboratories, Inc. answer due 3/27/2017. Ordered by Judge Gregory M. Sleet on 2/22/2017. (mdb)

2017-02-22

1

No Actions

SO ORDERED

2017-02-27

1

No Actions

SO ORDERED - re (11 in 1:17-cv-00039-GMS) MOTION for Pro Hac Vice Appearance of Attorney Paul H. Berghoff, Alison J. Baldwin, Paula S. Fritsch, and Brandon J. Kennedy filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC, (11 in 1:17-cv-00027-GMS) MOTION for Pro Hac Vice Appearance of Attorney Paul H. Berghoff, Alison J. Baldwin, Paula S. Fritsch, Ann C. Palma, and Brandon J. Kennedy filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC, (11 in 1:16-cv-01333-GMS) MOTION for Pro Hac Vice Appearance of Attorney Paul H. Berghoff, Alison J. Baldwin, Paula S. Fritsch, Ann C. Palma, and Brandon J. Kennedy filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC, (11 in 1:16-cv-01326-GMS) MOTION for Pro Hac Vice Appearance of Attorney Paul H. Berghoff, Alison J. Baldwin, Paula S. Fritsch, Ann C. Palma, and Brandon J. Kennedy filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC, (11 in 1:17-cv-00004-GMS) MOTION for Pro Hac Vice Appearance of Attorney Paul H. Berghoff, Alison J. Baldwin, Paula S. Fritsch, Ann C. Palma, and Brandon J. Kennedy filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC, (15 in 1:16-cv-01330-GMS) MOTION for Pro Hac Vice Appearance of Attorney Paul H. Berghoff, Alison J. Baldwin, Paula S. Fritsch, Ann C. Palma, and Brandon J. Kennedy filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC, (9 in 1:17-cv-00019-GMS) MOTION for Pro Hac Vice Appearance of Attorney Paul H. Berghoff, Alison J. Baldwin, Paula S. Fritsch, Ann C. Palma, and Brandon J. Kennedy filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC, (10 in 1:17-cv-00003-GMS) MOTION for Pro Hac Vice Appearance of Attorney Paul H. Berghoff, Alison J. Baldwin, Paula S. Fritsch, Ann C. Palma, Brandon J. Kennedy filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC, (11 in 1:17-cv-00070-GMS) MOTION for Pro Hac Vice Appearance of Attorney Paul H. Berghoff, Alison J. Baldwin, Paula S. Fritsch, Ann C. Palma, and Brandon J. Kennedy filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC, (9 in 1:17-cv-00040-GMS) MOTION for Pro Hac Vice Appearance of Attorney Paul H. Berghoff, Alison J. Baldwin, Paula S. Fritsch, Ann C. Palma, and Brandon J. Kennedy filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC, (11 in 1:16-cv-01300-GMS) MOTION for Pro Hac Vice Appearance of Attorney Paul H. Berghoff, Alison J. Baldwin, Paula S. Fritsch, Ann C. Palma, and Brandon J. Kennedy filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. Ordered by Judge Gregory M. Sleet on 2/27/2017. Associated Cases: 1:17-cv-00003-GMS et al.(mdb)

2017-02-27

1

No Actions

Pro Hac Vice Attorney Paul H. Berghoff, Alison J. Baldwin, Paula S. Fritsch, Ann C. Palma, Brandon J. Kennedy for Aventisub LLC,for Genzyme Corporation, for Sanofi, and for Sanofi-Aventis U.S. LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm)

2017-03-08

1

No Actions

Add Attorneys - PHV only

2017-03-08

1

No Actions

STIPULATION TO EXTEND TIME To Answer, Move or Otherwise Respond to the Complaint to April 10, 2017 - filed by IMPAX Laboratories, Inc.. (Phillips, John) (Entered: 03/22/2017)

2017-03-22

1

View

SO ORDERED - re 12 STIPULATION TO EXTEND TIME To Answer, Move or Otherwise Respond to the Complaint to April 10, 2017 filed by IMPAX Laboratories, Inc., Set/Reset Answer Deadlines: IMPAX Laboratories, Inc. answer due 4/10/2017. Ordered by Judge Gregory M. Sleet on 3/22/2017. (mdb)

2017-03-22

1

No Actions

~Util - Set/Reset Answer Deadline AND SO ORDERED

2017-03-22

1

No Actions

STIPULATION TO EXTEND TIME to Move, Answer or Otherwise Respond to the Complaint to May 1, 2017 - filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. (Bove, Jeffrey) (Entered: 04/07/2017)

2017-04-07

1

View

SO ORDERED - re 13 STIPULATION TO EXTEND TIME to Move, Answer or Otherwise Respond to the Complaint to May 1, 2017 filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC, Set/Reset Answer Deadlines: IMPAX Laboratories, Inc. answer due 5/1/2017. Ordered by Judge Gregory M. Sleet on 4/10/2017. (mdb)

2017-04-10

1

No Actions

~Util - Set/Reset Answer Deadline AND SO ORDERED

2017-04-10

1

No Actions

NOTICE of Voluntary Dismissal by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC as to Impax Laboratories, Inc. (Bove, Jeffrey) (Entered: 04/20/2017)

2017-04-20

1

View

CASE CLOSED (mdb)

2017-04-21

1

No Actions

Terminate Case - Civil

2017-04-21

1

No Actions

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (Attachments: # 1 Dismissal)(mdb) (Entered: 04/26/2017)

2017-04-26

1

View

Overview

Parties

Defendant

Sanofi Follow

Represented By

Sanofi-Aventis U.S. LLC Follow

Represented By

Plaintiff

Aventisub LLC Follow

Represented By

IMPAX Laboratories, Inc. Follow

Represented By

Genzyme Corporation Follow

Represented By

Court & Judges

Patents Involved

Docket Entries

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jcs) (Entered: 01/03/2017)

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: November 21, 2016. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 5/21/2019. (jcs) (Entered: 01/03/2017)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 6,794,410 C1; US 9,186,346 B2. (jcs) (Entered: 01/03/2017)

No Summons Issued

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sanofi for Aventisub LLC, Genzyme Corporation, Sanofi-Aventis U.S. LLC filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. (Bove, Jeffrey) (Entered: 01/04/2017)

Summons Issued

Summons Issued with Magistrate Consent Notice attached as to IMPAX Laboratories, Inc. on 1/4/2017. (jcs)

SUMMONS Returned Executed by Genzyme Corporation, Sanofi-Aventis U.S. LLC, Aventisub LLC, Sanofi. IMPAX Laboratories, Inc. served on 1/4/2017, answer due 1/25/2017. (Bove, Jeffrey) (Entered: 01/05/2017)

Case Assigned/Reassigned

Case Assigned to Judge Gregory M. Sleet. Please include the initials of the Judge (GMS) after the case number on all documents filed. Associated Cases: 1:17-cv-00003-GMS, 1:17-cv-00004-GMS, 1:17-cv-00018-GMS, 1:17-cv-00019-GMS (rjb)

STIPULATION TO EXTEND TIME to Answer, Move or Otherwise Respond to Complaint to January 25, 2017 - filed by IMPAX Laboratories, Inc.. (Phillips, John) (Entered: 01/12/2017)

~Util - Set/Reset Answer Deadline AND SO ORDERED

SO ORDERED - re 7 STIPULATION TO EXTEND TIME to Answer, Move or Otherwise Respond to Complaint to January 25, 2017 filed by IMPAX Laboratories, Inc., Set/Reset Answer Deadlines: IMPAX Laboratories, Inc. answer due 2/24/2017. Ordered by Judge Gregory M. Sleet on 1/17/2017. (mdb)

NOTICE of Appearance by David A. Bilson on behalf of IMPAX Laboratories, Inc. (Bilson, David) (Entered: 01/18/2017)

Amended Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 11/21/2016. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 3/12/2020. (Bove, Jeffrey) (Entered: 01/20/2017)

STIPULATION TO EXTEND TIME To Answer, Move or Otherwise Respond to the Complaint to March 27, 2017 - filed by IMPAX Laboratories, Inc.. (Phillips, John) (Entered: 02/17/2017)

MOTION for Pro Hac Vice Appearance of Attorney Paul H. Berghoff, Alison J. Baldwin, Paula S. Fritsch, Ann C. Palma, and Brandon J. Kennedy - filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. (Bove, Jeffrey) (Entered: 02/22/2017)

~Util - Set/Reset Answer Deadline AND SO ORDERED

SO ORDERED - re 10 STIPULATION TO EXTEND TIME To Answer, Move or Otherwise Respond to the Complaint to March 27, 2017 filed by IMPAX Laboratories, Inc., Set/Reset Answer Deadlines: IMPAX Laboratories, Inc. answer due 3/27/2017. Ordered by Judge Gregory M. Sleet on 2/22/2017. (mdb)

SO ORDERED

Add Attorneys - PHV only

STIPULATION TO EXTEND TIME To Answer, Move or Otherwise Respond to the Complaint to April 10, 2017 - filed by IMPAX Laboratories, Inc.. (Phillips, John) (Entered: 03/22/2017)

SO ORDERED - re 12 STIPULATION TO EXTEND TIME To Answer, Move or Otherwise Respond to the Complaint to April 10, 2017 filed by IMPAX Laboratories, Inc., Set/Reset Answer Deadlines: IMPAX Laboratories, Inc. answer due 4/10/2017. Ordered by Judge Gregory M. Sleet on 3/22/2017. (mdb)

~Util - Set/Reset Answer Deadline AND SO ORDERED

STIPULATION TO EXTEND TIME to Move, Answer or Otherwise Respond to the Complaint to May 1, 2017 - filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. (Bove, Jeffrey) (Entered: 04/07/2017)

~Util - Set/Reset Answer Deadline AND SO ORDERED

NOTICE of Voluntary Dismissal by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC as to Impax Laboratories, Inc. (Bove, Jeffrey) (Entered: 04/20/2017)

CASE CLOSED (mdb)

Terminate Case - Civil

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (Attachments: # 1 Dismissal)(mdb) (Entered: 04/26/2017)

Track Case Updates

Sanofi

Sanofi-Aventis U.S. LLC

Aventisub LLC

IMPAX Laboratories, Inc.

Genzyme Corporation